Diagnosis and treatment of chronic immune-mediated neuropathies

Journal of Clinical Neuromuscular Disease

Volumn 7, Issue 3, 2006, Pages 141-157

  Latov, Norman ^a,s   Gorson, Kenneth C ^b   Brannagan III, Thomas H ^a   Freeman, Roy L ^c   Apostolski, Slobodan ^d   Berger, Alan R ^e   Bradley, Walter G ^f   Briani, Chiara ^g   Bril, Vera ^h   Busis, Neil A ⁱ   Cros, Didier P ^c   Dalakas, Marinos C ^j   Donofrio, Peter D ^k   Dyck, P James B ^l   England, John D ^m   Fisher, Morris A ⁿ   Herrmann, David N ^o   Menkes, Daniel L ^p   Sahenk, Zarife ^q   Sander, Howard W ^a   Triggs, William J ^e   Vallat, Jean Michel ^r   more..

^a Cornell University ^*  (Serbia)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

^c HARVARD UNIVERSITY   (United States)

^d UNIVERSITY OF BELGRADE   (Serbia)

^e UNIVERSITY OF FLORIDA   (United States)

^f UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF PADOVA   (Italy)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ UNIVERSITY OF PITTSBURGH   (United States)

^j NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^k WAKE FOREST UNIVERSITY   (United States)

^l MAYO CLINIC   (United States)

^m Billings Clinic Red Lodge   (United States)

ⁿ HINES VA HOSPITAL   (United States)

^o UNIVERSITY OF ROCHESTER   (United States)

^p UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^q OHIO STATE UNIVERSITY   (United States)

^r DUPUYTREN UNIVERSITY HOSPITAL   (France)

^s WEILL CORNELL MEDICAL COLLEGE   (United States)

more..

Author keywords

Autoimmune neuropathy; Diagnosis; Inflammatory neuropathy; Peripheral neuropathy; Therapy; Vasculitic neuropathy

Indexed keywords

ALPHA2B INTERFERON; ANTIINFECTIVE AGENT; AZATHIOPRINE; BETA INTERFERON; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETANERCEPT; FLUDARABINE; IMMUNOGLOBULIN; INFLIXIMAB; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB;

AUTONOMIC NEUROPATHY; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CHURG STRAUSS SYNDROME; CRYOGLOBULINEMIA; GANGLIONEURITIS; HUMAN; MICROSCOPIC POLYANGIITIS; MOTOR NEUROPATHY; NEUROPATHY; PARANEOPLASTIC NEUROPATHY; POLYARTERITIS NODOSA; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SCLERODERMA; SENSORY NEUROPATHY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; SYSTEMIC VASCULITIS; TEMPORAL ARTERITIS; VASCULITIS; WARTENBERG NEUROPATHY; WEGENER GRANULOMATOSIS;

EID: 33749444606     PISSN: 15220443     EISSN: 15371611     Source Type: Journal    
DOI: 10.1097/01.cnd.0000205575.26451.e4     Document Type: Review

References (194)

1. Dyck PJ, Lais AC, Ohta M, et al. Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc. 1975;50:621-637.
2. Mccombe PA, Pollard JD, Mcleod JG. Chronic inflammatory demyelinating polyradiculoneuropathy - a clinical and electrophysiological study of 92 cases. Brain. 1987;110:1617-1630.
3. Barohn RJ, Kissel JT, Warmolts JR, et al. Chronic inflammatory demyelinating polyradiculoneuropathy - clinical characteristics, course, and recommendations for diagnostic-criteria. Arch Neurol. 1989;46:878-884.
4. Gorson KC, Allam G, Ropper AH. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology. 1997;48:321-328.
5. Rotta FT, Sussman AT, Bradley WG, et al. The spectrum of chronic inflammatory demyelinating polyneuropathy. J Neurol Sci. 2000;173:129-139.
6. The Neuropathy Association. Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst. 2003;8:282-284.
7. Bouchard C, Lacroix C, Plante V, et al. Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology. 1999;52:498-503.
8. Lewis RA, Sumner AJ, Brown MJ, et al. Multifocal demyelinating neuropathy with persistent conduction block. Neurology. 1982;32:958-964.
9. Chin RL, Latov N, Sander HW, et al. Chronic inflammatory demyelinating polyneuropathy presenting as cryptogenic sensory polyneuropathy. J Peripher Nerv Syst. 2004;9:128-133.
10. Sinnreich M, Klein CJ, Daube JR, et al. Chronic immune sensory polyradiculopathy. A possibly treatable sensory ataxia. Neurology. 2004;63:1662-1669.
11. Gondim FA, Brannagan TH, Sander HW, et al. Peripheral neuropathy in patients with inflammatory bowel disease. Brain. 2005;128:867-879.
12. Cornblath DR. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology. 1991;41:617-618.
13. Magda P, Latov N, Brannagan TH, et al. Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with CIDP. Arch Neurol. 2003;60:1755-1759.
14. Viala K, Renie L, Maisonobe T, et al. Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome. Brain. 2004;127:2010-2017.
15. Vallat JM, Tabaraud F, Magy L, et al. Diagnostic value of nerve biopsy for atypical chronic inflammatory demyelinating polyneuropathy: evaluation of eight cases. Muscle Nerve. 2003;27:478-485.
16. Dyck PJ, Dyck PJB, Engelstad J. Pathological alterations of nerves. In: Dyck PJ, Thomas PK, eds. Peripheral Neuropathy. 4th ed. PHILA, PA: Elsevier Inc; 2005:733-830; Chapter 32.
17. Dalakas MC, Engel WK. Chronic relapsing (dysimmune) polyneuropathy pathogenesis and treatment. Ann Neurol. 1981;9:134-145.
18. Taylor BV, Wright RA, Harper CM, et al. Natural history of 46 patients with multifocal motor neuropathy with conduction block. Muscle Nerve. 2000;23:900-908.
19. Nobile-Orazio E, Cappellari A, Meucci N, et al. Multifocal motor neuropathy: clinical and immunological features and response to IVIg I relation to the presence and degree of motor conduction block. J Neurol Neurosurg Psychiatry. 2002;72:761-766.
20. Chaudhry V, Corse AM, Cornblath DR, et al. Multifocal motor neuropathy: electrodiagnostic features. Muscle Nerve. 1994;17:198-205.
21. Katz JS, Barohn RJ, Kojan S, et al. Axonal multifocal neuropathy without conduction block or other features of demyelination. Neurology. 2002;58:615-620.
22. Kinsella LJ, Lange DJ, Trojaborg W, et al. Clinical and electrophysiologic correlates of elevated anti-Gm(1) antibody-titers. Neurology. 1994;44:1278-1282.
23. Taylor BV, Gross L, Windebank AJ. The sensitivity and specificity of anti-Gm1 antibody testing. Neurology. 1995;45:A398.
24. Taylor BV, Dyck RJB, Engelstad J, et al. Multifocal motor neuropathy: pathologic alterations at the site of conduction block. J Neuropathol Exp Neurol. 2004;63:129-137.
25. Nobile-Orazio E, Manfredini E, Carpo M, et al. Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann Neurol. 1994;36:416-424.
26. Caudie C, Vital C, Petiot P, et al. Monoclonal IgM autoantibody activity vis-à-vis glycoconjugates of peripheral nerves, apropos of 112 cases . Ann Biol Clin (Paris). 2001;59:567-577.
27. Eurelings M, Ang CW, Nottermans NC, et al. Antiganglioside antibodies in polyneuropathy associated with monoclonal gammopathy. Neurology. 2001;57:1909-1912.
28. Lopate G, Choksi R, Pestronk A. Severe sensory ataxia and demyelinating polyneuropathy with IgM anti-GM2 and GalNAc-GD1a antibodies. Muscle Nerve. 2002;25:828-836.
29. Dabby R, Weimer LH, Hays AP, et al. Antisulfatide antibodies in neuropathy, clinical and electrophysiologic correlates. Neurology. 2000;54:1448-1452.
30. Renaud S, Steck A, Latov N. Neuropathies associated with monoclonal gammopathies. In: Antel J, Birnbaum G, Hartung H-P, Vincent A, eds. Clinical Immunology. 2nd ed. Oxford, Queenland: Oxford University Press; 2005:327-338; Chapter 26.
31. Kelly JJ Jr, Kyle RA, O'Brien PC, et al. Prevalence of monoclonal protein in peripheral neuropathy. Neurology. 1981;31:1480-1483.
32. Willison HJ, O'Leary CP, Veitch J, et al. The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. Brain. 2001;124:1968-1977.
33. Freddo L, Yu RK, Latov N, et al. Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patient with motor neuron disease. Neurology. 1986;36:454-458.
34. Ortiz N, Rosa R, Gallardo E, et al. IgM monoclonal antibody against terminal moiety of GM2, GalNAc-GD1a and GalNAc-GM1b from a pure motor chronic demyelinating polyneuropathy patient, effects on neurotransmitter release. J Neuroimmunol. 2001;119:114-123.
35. Latov N. Prognosis of neuropathy withmonoclonal gammopathy. Muscle Nerve. 2000;23:150-152.
36. Kaku DA, England JD, Sumner AJ. Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulfated glucuronyl paragloboside. Brain. 1994;117:941-947.
37. Latov N, Hays AP, Sherman WH. Peripheral neuropathy and anti-MAG antibodies. Crit Rev Neurobiol. 1988;3:301-332.
38. Vital A, Vital C, Jilien J, et al. Polyneuropathies associated with IgM monoclonal gammopathy. Immunological and pathological study in 31 patients. Acta Neuropathol (Berlin). 1989;79:160-167.
39. Dyck PJ, Litchy WJ, Kratz KM, et al. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol. 1994;36:838-845.
40. Hahn AF, Bolton CF, Zochodne D, et al. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study. Brain. 1996;119(Pt 4):1067-1077.
41. Hughes R, Bensa S, Willison H, et al. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol. 2001;50:195-201.
42. Mendell JR, Barohn RJ, Freimer ML, et al. Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology. 2001;56:445-449.
43. Dyck PJ, Daube J, Obrien P, et al. Plasma-exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med. 1986;314:461-465.
44. Hahn AF, Bolton CF, Pillay N, et al. Plasma exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, shamcontrolled, cross-over study. Brain. 1996;119(Pt 4):1055-1066.
45. Dyck PJ, Obrien PC, Oviatt KF, et al. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol. 1982;11:136-141.
46. Dyck PJ, Obrien P, Swanson C, et al. Combined azathioprine and prednisone in chronic inflammatory-demyelinating polyneuropathy. Neurology. 1985;35:1173-1176.
47. Hadden RDM, Sharrack B, Bensa S, et al. Randomized trial of interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology. 1999;53:57-61.
48. Good JL, Chehrenama M, Mayer RF, et al. Pulse cyclophosphamide therapy in chronic inflammatory demyelinating polyneuropathy. Neurology. 1998;51:1735-1738.
49. Brannagan TH, Pradhan A, Heiman-Patterson T, et al. High-dose cyclophosphamide without stem-cell rescue for refractory CIDP. Neurology. 2002;58:1856-1858.
50. Barnett MH, Pollard JD, Davies L, et al. Cyclosporin A in resistant chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 1998;21:454-460.
51. Mahattanakul W, Crawford TO, Griffin JW, et al. Treatment of chronic inflammatory demyelinating polyneuropathy with cyclosporin-A. J Neurol Neurosurg Psychiatry. 1996;60:185-187.
52. Chaudhry V, Cornblath DR, Griffin JW, et al. Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases. Neurology. 2001;56:94-96.
53. Mowzoon N, Sussman A, Bradley WG. Mycophenolate (CellCept) treatment of myasthenia gravis, chronic inflammatory polyneuropathy and inclusion body myositis. J Neurol Sci. 2001;185:119-122.
54. Gorson KC, Amato AA, Ropper AH. Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy. Neurology. 2004;63:715-717.
55. Umpathi T, Hughes R. Mycophenolate in treatment-resistant inflammatory neuropathies. Eur J Neurol. 2002;9:683-685.
56. Vallat JM, Hahn AF, Leger JM, et al. Interferon beta-1a as an investigational treatment for CIDP. Neurology. 2003;60:S23-S28.
57. Choudhary PP, Thompson N, Hughes RAC. Improvement following interferon beta in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol. 1995;242:252-253.
58. Kantzer T, Radziwill AJ, Lettry-Trouillat R, et al. Interferon-B1a in chronic inflammatory demyelinating polyneuropathy. Neurology. 1999;53:1364-1365.
59. Chin RL, Sherman WH, Sander HW, et al. Etanercept (Enbrel (R)) therapy for chronic inflammatory demyelinating polyneuropathy. J Neurol Sci. 2003;210:19-21.
60. Choudhary PP, Hughes RA. Long-term treatment of chronic inflammatory demyelinating polyradiculoneuropathy with plasma exchange or intravenous immunoglobulin. QJM. 1995;88:493-502.
61. Gorson KC, Allam G, Simovic D, et al. Improvement following interferon-alpha 2A in chronic inflammatory demyelinating polyneuropathy. Neurology. 1997;48:777-780.
62. Vermeulen M, Van Oers MH. Successful autologous stem cell transplantation in a patient with chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry. 2002;72:127-128.
63. Azulay JP, Blin O, Pouget J, et al. Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind, placebo controlled trial. Neurology. 1994;44:429-432.
64. vandenBerg LH, Kerkhoff H, Oey PL, et al. Treatment of multifocal motor neuropathy with high-dose intravenous immunoglobulins - a double-blind, placebo-controlled study. J Neurol Neurosurg Psychiatry. 1995;59:248-252.
65. Federico P, Zochodne DW, Hahn AF, et al. Multifocal motor neuropathy improved by IVIg - randomized, double-blind, placebo-controlled study. Neurology. 2000;55:1256-1262.
66. Leger JM, Chassande B, Musset L, et al. Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study. Brain. 2001;124:145-153.
67. Feldman EL, Bromberg MB, Albers JW, et al. Immunosuppressive treatment in multifocal motor neuropathy. Ann Neurol. 1991;30:397-401.
68. Levine TD, Pestronk A. IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using rituximab. Neurology. 1999;52:1701-1704.
69. Pestronk A, Florence J, Miller T, et al. Treatment of IgM antibody associated polyneuropathies using rituximab. J Neurol Neurosurg Psychiatry. 2003;74:485-489.
70. Rojas-Garcia R, Gallardo E, de Andres I, et al. Chronic neuropathy with IgM anti-ganglioside antibodies: lack of long term response to rituximab. Neurology. 2003;61:1814-1816.
71. Martina IS, van Doorn PA, Schmitz PI, et al. Chronic motor neuropathies: response to interferon-beta1a after failure of conventional therapies. J Neurol Neurosurg Psychiatry. 1999;66:197-201.
72. Van den Berg-Vos RM, van den Berg LH, Franssen H, et al. Treatment of multifocal motor neuropathy with interferon-beta1A. Neurology. 2000;54:1518-1521.
73. Nemni R, Santuccio G, Calabrese E, et al. Efficacy of cyclosporine treatment in multifocal motor neuropathy. J Neurol. 2003;250:1118-1120.
74. Donaghy M, Mills KR, Boniface SJ, et al. Pure motor demyelinating neuropathy - deterioration after steroid treatment and improvement with intravenous immunoglobulin. J Neurol Neurosurg Psychiatry. 1994;57:778-783.
75. Vucic S, Black KR, Chong PS, et al. Multifocal motor neuropathy: decrease in conduction blocks ad reinnervation with long term IVIg. Neurology. 2004;63:1264-1269.
76. Latov N, Hays AP, Donofrio PD, et al. Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b, and to lacto-N-tetraose, associated with human motor neuron disease. Neurology. 1988;38:763-768.
77. Carpo M, Capperllari A, Mora G, et al. Deterioration of multifocal motor neuropathy after plasma exchange. Neurology. 1998;50:1480-1482.
78. Comi G, Roveri L, Swan A, et al. A randomized controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy. J Neurol. 2002;249: 1370-1377.
79. Renaud S, Gregor M, Fuhr P, et al. Rituximab and anti-MAG associated polyneurpathy. Muscle Nerve. 2003;27:611-615.
80. Gorson KC, Ropper AH, Weinberg DH, et al. Treatment experience in patients with anti-myelin associated glycoprotein neuropathy. Musce Nerve. 2001;24:778-786.
81. Dalakas MC, Quarles RH, Farrer RG, et al. A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy. Ann Neurol. 1996;40:792-795.
82. Carpo M, Nobile-Orazio E, Meucci N, et al. Anti-GD1a ganglioside antibodies in peripheral motor syndromes. Ann Neurol. 1996;39:539-543.
83. Oksenhendler E, Chevret S, Leger JM, et al. Plasma exchange and chrlorambucil in polyneuropathy associated with monoclonal gammopathy. IgM gammopathy study group. J Neurol Neurosurg Psychiatry. 1995;59:243-247.
84. Wilson HC, Lunn MP, Schey S, et al. Successful treatment of IgM paraproteinemic neuropathy with fludarabine. J Neurol Neurosurg Psychiatry. 1999;66:575-580.
85. Corbo M, Abouzahr MK, Latov N, et al. Successful treatment of IgM paraproteinemic neuropathy with fludarabine. J Neurol Neurosurg Psychiatry. 1999;66:575-580.
86. Blume G, Pestronk A, Goodnough LT. Anti-MAG antibody associated polyneuropathies. Improvement following chemotherapy with monthly plasma exchange and IV cyclophosphamide. Neurology. 1995;45:1577-1580.
87. Ghosh A, Littlwood T, Donaghy M. Cladrabine in the treatment of IgM paraproteinemic polyneuropathy. Neurology. 2002;59:1290-1129.
88. Rudicki SA, Harik SI, Dhodapkar M, et al. Nervous system dysfunction in Waldenstrom's macroglobulinemia; response to treatment. Neurology. 1998;51:1210-1213.
89. Cohen RD, Conn DL, Ilstrup DM. Clinical features, prognosis and response to treatment in polyarteritis. Mayo Clin Proc. 1980;3:146-155.
90. Guillevin L, Le Thi Huong D, Godeau P, et al. Clinical findings and prognosis of polyarteritis nodosa and Churg-Strauss angiitis: a study in 165 patients. Br J Rheumatol. 1988;27:258-264.
91. Guillevin L, Lhote F, Cohen P, et a1. Polyarteritis nodosa related to hepatitis B virus: a prospective study with long-term observation of 41 patients. Medicine. 1995;74:238-253.
92. Guillevin L, Lhote F, Fherardi R. Polyarteritis nodosa, microscopic polyangiitis, and Churg Strauss syndrome; clinical aspects, neurological manifestations, and treatment. Neurol Clin. 1997;15:865-886.
93. Hattori N, Ichimura M, Nagamatsu M, et a1. Clinicopathological features of Churg-Strauss syndrome-associated neuropathy. Brain. 1999;122:427-439.
94. Guillevin L, Cohen P, Gayraud M, et al. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine. 1999;78:26-37.
95. Marazzi R, Pareyson D, Boiardi A, et al. Peripheral nerve involvement in Churg-Strauss syndrome. J Neurol. 1992;239:317-321.
96. De Groot K, Schmidt DK, Arlt AC, et al. Standardized neurologic evaluations of 128 patients with Wegener granulomatosis. Arch Neurol. 2001;48:1215-1221.
97. Nishino H, Rubino FA, Parisi JE. The spectrum of neurologic involvement in Wegener's granulomatosis. Neurology. 1993;43:1334-1337.
98. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992;116:488-498.
99. Caselli RJ, Daube JR, Hunder GG, et al. Peripheral neuropathic syndromes in giant cell (temporal) arteritis. Neurology. 1988;38:685-689.
100. Nesher G, Rosenberg P, Shorer Z, et al. Involvement of the peripheral nervous system in temporal arteritis-polymyalgia rheumatica. Report of 3 cases and review of the literature. J Rheumatol. 1987;14:358-360.
101. Golbus J, McCune WJ. Giant cell arteritis and peripheral neuropathy: a report of 2 cases and review of the literature. J Rheumatol. 1987;14:129-134.
102. Puechal X, Said G, Hilliquin P, et al. Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis. A clinicopathologic and prognostic study of thirty-two patients. Arthritis Rheum. 1995;38:1618-1629.
103. Scott DG, Bacon PA, Tribe CR. Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine. 1981;60:288-297.
104. Weller RO, Bruckner FE, Chamberlain MA. Rheumatoid neuropathy: a histological and electrophysiological study. J Neurol Neurosurg Psychiatry. 1970;33:592-604.
105. Johnson RT, Richardson EP. The neurological manifestations of systemic lupus. Medicine. 1968;47:337-369.
106. McCombe PA, McLeod JG, Pollard JD, et al. Peripheral sensorimotor and autonomic neuropathy associated with systemic lupus erythematosus. Clinical, pathological and immunological features. Brain. 1987;110:533-549.
107. Omdal R, Henriksen OA, Mellgren SI, et al. Peripheral neuropathy in systemic lupus erythematosus. Neurology. 1991;41:808-811.
108. Grant IA, Hunder GG, Homburger HA, et al. Peripheral neuropathy associated with sicca complex. Neurology. 1998;51:650-651.
109. Mellgren SI, Conn DL, Steven JC, et al. Peripheral neuropathy in primary Sjogren's syndrome. Neurology. 1989;39:390-394.
110. Griffin JW, Cornblath DR, Alexander E. Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjogren's syndrome. Ann Neurol. 1990;27:304-315.
111. Chai J, Herrmann DN, Stanton M, et al. Painful small fiber neuropathy in Sjogren syndrome. Neurology. 2005;65:925-927.
112. Dyck PJ, Hunder GG, Dyck PJ. A case control and nerve biopsy study of CREST multifple mononeuropathy. Neurology. 1997;49:1641-1645.
113. Averbuch-Heller L, Steiner I, Abramsky O. Neurologic manifestations of progressive systemic sclerosis. Arch Neurol. 1992;49:1292-1295.
114. Corbo M, Nemni R, Lannaccone S, et al. Peripheral neuropathy in scleroderma. Clin Neuropathol. 1993;12:63-67.
115. Lacomis D, Giuliani MJ, Steen V, et al. Small fiber neuropathy and vasculitis. Arthritis Rheum. 1997;40:1173-1177.
116. Allanore Y, Zuber M, Kahan A. Brachial plexopathy associated with systemic sclerosis. Clin Rheumatol. 2002;21:401-402.
117. Khella SL, Frost S, Hermann GA, et al. Hepatitis C infection, cryoglobulinemia, and vasculitic neuropathy. Treatment with interferon alfa: case report and literature review. Neurology. 1995;45:407-411.
118. Ferri C, La Civita L, Cirafisi C, et al. Peripheral neuropathy in mixed cryoglobulinemia: clinical and electrophysiologic investigations. J Rheumatol. 1992;19:889-895.
119. Cavaletti G, Petruccioli MG, Crespi V, et al. A clinico-pathological and follow up study of 10 cases of essential type II cryoglobulinaemic neuropathy. J Neurol Neurosurg Psychiatry. 1990;53:886-889.
120. Nemni R, Corbo M, Fazio R, et al. Cryoglobulinemic neuropathy. A clinical, morphological and immunocytochemical study of 8 cases. Brain. 1988;111:541-552.
121. Garcia-Bragado F, Femandez JM, Navarro C, et al. Peripheral neuropathy in essential mixed cryoglobulinemia. Arch Neurol. 1988;45:1210-1214.
122. Apartis E, Leger JM, Musset L, et al. Peripheral neuropathy associated with essential mixed cryoglobulinemia: a role for hepatitis C virus infection? J Neurol Neurosurg Psychiatry. 1996;60:661-666.
123. Stafford CR, Bogdanoff BM, Green L, et al. Mononeuropathy multiplex as a complication of amphetamine angiitis. Neurology. 1975;25:570-572.
124. Merkel PA. Drug-induced vasculitis. Rheum Dis Clin North Am. 2001;27:849-862.
125. Dyck PJ, Benstead TJ, Conn DL, et al. Nonsystemic vasculitic neuropathy. Brain. 1987;110:834-853.
126. Kissel JT, Slivka AP, Warmolts JR, et al. The clinical spectrum of necrotizing angiopathy of the peripheral nervous system. Ann Neurol. 1985;18:251-257.
127. Collins MP, Mendell JR, Periquet MI, et al. Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy. Neurology. 2000;55:636-643.
128. Collins MP, Periquet MI, Mendell JR, et al. Nonsystemic vasculitic neuropathy: insights from a clinical cohort. Neurology. 2003;61:623-630.
129. Hellmann DB, Laing TJ, Petri M, et al. Mononeuritis multiplex: the yield of evaluations for occult rheumatic diseases. Medicine. 1988;67:145-153.
130. Logigian EL, Shefner JM, Frosch MP, et al. Nonvasculitic, steroid-responsive mononeuritis multiplex. Neurology. 1993;43:879-883.
131. Alaedini A, Sander HW, Hays AP, et al. Antiganglioside antibodies in multifocal acquired sensory and motor neuropathy. Arch Neurol. 2003;60:42-46.
132. Magda P, Latov N, Brannagan TH. Multifocal acquired sensory and motor neuropathy; electrodiagnostic features. J Clin Neuromusc Dis. 2005;7:10-18.
133. Allen RK, Sellars RE, Sandstrom PA. A prospective study of 32 patients with neurosarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2003;20:118-125.
134. Said G, Lacroix C, Plante-Bordeneuve V, et al. Nerve granulomas and vasculitis in sarcoid peripheral neuropathy: a clinicopathological study of 11 patients. Brain. 2002;125:264-275.
135. Jayne D, Rasmussen N, Andrassy K, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med. 2003;349:36-44.
136. Tsurikisawa N, Taniguchi M, Saito H, et al. Treatment of Churg-Strauss syndrome with high dose intravenous gammaglobulin. Ann Allergy Asthma Immunol. 2004;92:80-87.
137. Martinez-Taboada VM, Alonso RB, Armona J, et al. Mononeuritis multiplex in systemic lupus erythematosus: response to pulse intravenous cyclophosphamide. Lupus. 1996;5:74-76.
138. Levy Y, Uziel Y, Zandman GG, et al. Intravenous immunoglobulins in peripheral neuropathy associated with vasculitis. Ann Rheum Dis. 2003;62:1221-1223.
139. Font J, Ramos-Casals M, de la Red G, et al. Pure sensory neuropathy in primary Sjogren's syndrome. Long term prospective follow-up and review of the literature. J Rheumatol. 2003;30:1552-1557.
140. Naarendorp M, Kallemuchikkal U, Nuovo GJ, et al. Long-term efficacy of interferon-alpha for extrahepatic disease associated with hepatitis C virus infection. J Rheumatol. 2001;28:2466-2473.
141. Sobue G, Yasuda T, Kachi T, et al. Chronic progressive sensory ataxic neuropathy: clinicopathological features of idiopathic and Sjogren's syndrome associated cases. J Neurol. 1993;240:1-7.
142. McDermott WR, Kelkar PM, Parry GJ. Cryptogenic painful neuropathy: is there an inflammatory basis ? Neurology. 2000;54(Suppl 3):A71.
143. Kelkar P, McDermott WR, Parry GJ. Sensory predominant, painful idiopathic neuropathy; inflammatory changes in sural nerves. Muscle Nerve. 2002;26:413-416.
144. Gorson KC, Roper AH. Idiopathic distal small fiber neuropathy. Acta Neurol Scand. 1995;92:376-380.
145. Cavaletti G, Santoro P, Agostoni E, et al. Chronic axonal sensory and autonomic polyneuropathy without motor involvement: a new chronic inflammatory neuropathy? Eur J Neurol. 1999;6:249-253.
146. Griffin JW, Cornblath DR, Alexander E, et al. Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjögren's syndrome. Ann Neurol. 1990;27:304-315.
147. Mori K, Iijima M, Sugiura M, et al. Sjogren's syndrome associated painful sensory neuropathy without sensory ataxia. J Neurol Neurosurg Psychiatry. 2003;74:1320-1322.
148. Font J, Ramos-Casals M, de la Red G, et al. Pure sensory neuropathy in primary Sjogren's syndrome. Long term prospective folloup and review of the literature. J Rheumatol. 2003;30:1552-1557.
149. Grant IA, Hunder GG, Homburger HA, et al. Peripheral neuropathy associated with sicca complex. Neurology. 1997;48:855-862. .
150. Graus F, Keime-Guibert F, Rene R, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain. 2001;124:1138-1148.
151. Gorson KC, Roper AH. Positive salivary gland biopsy, Sjogren syndrome, and neuropathy: clinical implications. Muscle Nerve. 2003;28:553-560.
152. Lacomis D. Small fiber neuropathy. Muscle Nerve. 2002;26:173-188.
153. Rubin DI, Daube JR. Subacute sensory neuropathy associated with Epstein-Barr virus. Muscle Nerve. 1999;22:1607-1610.
154. Chin RL, Sander HW, Brannagan TH, et al. Celiac neuropathy. Neurology. 2003;60:1581-1585.
155. Lopate G, Parks BJ, Goldstein JM, et al. Polyneuropathies associated with high titre antisulfatide antibodies: characteristics of patients with and without serum monoclonal proteins. J Neurol Neurosurg Psychiatry. 1997;62:581-585.
156. Dabby R, Weimer LH, Hays AP, et al. Antisulfatide antibodies in neuropathy: clinical and electrophysiologic correlates. Neurology. 2000;54:1448-1452.
157. Auger RG, Windebank AJ, Lucchinetti CF, et al. Role of the blink reflex in the evaluation of sensory neuronopathy. Neurology. 1999;53:407-408.
158. Graus F, Keime-Guibert F, Rene R, et al. Anti-HU associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain. 2001;124:1138-1148.
159. Camdessanche JP, Antoine JC, Honnorat J, et al. Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients. Brain. 2002;125:166-175.
160. Dalmau J, Graus F, Rosenblum MK, et al. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine. 1992;71:59-72.
161. Lucchinetti CF, Kimmel DW, Lennon VA. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology. 1998;50:652-657.
162. Lennon VA, Sas DF, Busk MF, et al. Enteric neuronal autoantibodies in psuedoobstruction with small cell lung carcinoma. Gastroenterology. 1991;100:137-142.
163. Yu Z, Kryzer TJ, Griesmann GE, et al. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol. 2001;49:146-154.
164. Zifko UA, Hahn AF. Migrant sensory neuropathy: report of 5 cases and review of the literature. J Peripher Nerv Syst. 1997;2:244-249.
165. Nicolle MW, Barron JR, Watson BV, et al. Wartenberg's migrant sensory neuritis. Muscle Nerve. 2001;24:438-443.
166. Suarez GA, Fealey RD, Camilleri M, et al. Idiopathic autonomic neuropathy: clinical, neurophysiologic, and follow-up studies on 27 patients. Neurology. 1994;44:1675-1682.
167. Hoyle C, Ewing DJ, Parker AC. Acute autonomic neuropathy in association with systemic lupus erythematosus. Ann Rheum Dis. 1985;44:420-424.
168. Arruda WO, Teive HA, Ramina R, et al. Autonomic neuropathy in systemic lupus erythematosus. J Neurol Neurosurg Psychiatry. 1989;52:539-540.
169. Kovacs L, Paprika D, Takacs R, et al. Cardiovascular autonomic dysfunction in primary Sjogren's syndrome. Rheumatology. 2004;43:95-99.
170. Sorajja P, Poirier MK, Bundrick JB, et al. Autonomic failure and proximal skeletal myopathy in a patient with primary Sjogren syndrome. Mayo Clin Proc. 1999;74:695-697.
171. Goto H, Matsuo H, Fukudome T, et al. Chronic autonomic neuropathy in a patient with primary Sjogren's syndrome. J Neurol Neurosurg Psychiatry. 2000;69:135.
172. Wright RA, Grant IA, Low PA. Autonomic neuropathy associated with sicca complex. J Auton Nerv Syst. 1999;75:70-76.
173. Sakakibara R, Hirano S, Asahina M, et al. Primary Sjogren's syndrome presenting with generalized autonomic failure. Eur J Neurol. 2004;11:635-638.
174. Yahr MD, Frontera AT. Acute autonomic neuropathy. Its occurrence in infectious mononucleosis. Arch Neurol. 1975;32:132-133.
175. Fujii N, Tabira T, Shibasaki H, et al. Acute autonomic and sensory neuropathy associated with elevated Epstein-Barr virus antibody titre [letter]. J Neurol Neurosurg Psychiatry. 1982;45:656-657.
176. Thomashefsky AJ, Horwitz SJ, Feingold MH. Acute autonomic neuropathy. Neurology. 1972;22:251-255.
177. Pavesi G, Gemignani F, Macaluso GM, et al. Acute sensory and autonomic neuropathy: possible association with coxsackie B virus infection. J Neurol Neurosurg Psychiatry. 1992;55:613-615.
178. Summers Q, Harris A. Autonomic neuropathy after rubella infection. Med J Aust. 1987;147:353-355.
179. Neville BG, Sladen GE. Acute autonomic neuropathy following primary herpes simplex infection. J Neurol Neurosurg Psychiatry. 1984;47:648-650.
180. Vernino S, Low PA, Fealey RD, et al. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med. 2000;343:847-855.
181. Klein CM, Vernino S, Lennon VA, et al. The spectrum of autoimmune autonomic neuropathies. Ann Neurol. 2003;53:752-758.
182. Chen WH, Yeh JH, Chiu HC. Plasmapheresis in the treatment of ataxic sensory neuropathy associated with Sjogren's syndrome. Eur Neurol. 2001;45:270-274.
183. Takauchi H, Misu K, Hattori N, et al. Immunoglobulin therapy in idiopathic chronic sensory ataxic neuropathy. Neurology. 2000;54:1008-1010.
184. Quijano-Roy S, Jones HR. Benefit of IVIg for long-standing ataxic sensory neuropathy with Sjogren's syndrome. Neurology. 2003;61:873.
185. Rubenstein AE, Horowitz SH, Bender AN. Cholinergic dysautonomia and Eaton-Lambert syndrome. Neurology. 1979;29:720-723.
186. Molina JA, Benito-Leon J, Bermejo F, et al. Intravenous immunoglobulin therapy in sensory neuropathy associated with Sjogren's syndrome. J Neurol Neurosurg Psychiatry. 1996;60:699.
187. Taguchi Y, Takashima S, Takata M, et al. Hight dose intravenous immunoglbulin in the treatment of sensory ataxic neuropathy with Sjogren's syndrome: a case report. No To Shinkei. 2004;56:421-424.
188. Caroyer JM, Manto MU, Steinfeld SD. Severe sensory neuronopathy responsive to infliximab in primary Sjogren's syndrome. Neurology. 2002;59:1113-1114.
189. Keime-Guibert F, Graus F, Broet P, et al. Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor. Neurology. 1999;53:1719-1723.
190. Keime-Guibert F, Graus F, Fleury A, et al. Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Psychiatry. 2000;68:479-482.
191. Vernino S, O'Neill BP, Marks RS, et al. Immunomodulatory treatment trial for paraneoplastic neurological disorders. Neuro-oncology. 2004;6:55-62.
192. Heafield MT, Gammage MD, Nightingale S, et al. Idiopathic dysautonomia treated with intravenous gammaglobulin. Lancet. 1996;347:28-29.
193. Mericle RA, Triggs WJ. Treatment of acute pandysautonomia with intravenous gammaglobulins. J Neurol Neurosurg Psychiatry. 1997;62:529-531.
194. Smit AA, Vermeulen M, Koelman JH, et al. Unusual recovery from acute panautonomic neuropathy after immunoglobulin therapy. Mayo Clin Proc. 1997;72:333-335.